3McDermott C, White K, Bushby K, et al. Hereditary spastic paraparesis: a review of new developments[J]. J Neurol Nettrosurg Psychiatry,2000,69(2) : 150 - 160.
4Burgunder JM, Hurmker W. Hereditary spastic paraplegia: cluez from a rare disorder for a common problem? [J]. IUBMB Life,2003,55(6) :347 - 352.
5Trouillas P, Xie J, Adeleine P, et al. Buspirone, a 5 -hydroxytryptaminel A agonist, is active in cerebellar ataxia. Results of a double- blind drug placebo study in patients with cerebellar cortical atrophy[J]. Arch Neurol, 1997,54(6) :749 - 752.
6Lou JS, Goldfarb L, McShane L, et al. Use of buspirone for treatment of cerebellar ataxia: an open - label study[J]. Arch Neurol, 1995,52(10) :982 - 988.
7Albright AL, Barron WB, Fasick MP, et al. Continuous intrathecal baclofen infusion for spasticity of cerebral origin[J]. JAMA, 1993,270(20) :2475 - 2477.
8Broggi G, Servello D, Brock S, et al. The treatment of spasticity by intrathecal administration of baclofen: a preliminary personal experience[J]. J Neurosurg Sci,1993,37(4):203 -208.
9Dan B, Cheron G. Intrathecal baclofen normalizes motor strategy for squatting in familial spastic paraplegia: a case study[J]. Neurophysiol Clin, 2000,30(1) :43 - 48.
10Detrembleur C, Lejeune TM, Plaghki L. Objective measures of muscle stiffness in the ankle. Evaluation of the effect of intrathecal injection of baclofen in spastic patients[J]. Neurochirurgie, 1998,44(3):197-200.
